NORwegian CardiOvasculaR (NORCOR) prevention research group

Approximately one-fifth of the population today lives with cardiovascular disease or is at high risk for developing such conditions. Cardiovascular disease and diabetes are the leading causes of morbidity, mortality, and reduced quality of life in Norway and worldwide.

The NORCOR research group works to prevent cardiovascular disease by generating new knowledge, developing, and testing evidence-based interventions targeting cardiovascular risk factors and psychological factors.

NORCOR is currently organized into four subgroups, focusing on:

1. Biopsychosocial factors (anxiety, depression, and insomnia). Group leader: Toril Dammen
2. Preventive medications (adherence and side effects). Group leaders:  Nils Tore Vethe and Elise Sverre.
3. Diabetes mellitus and other endocrinological research. Group leader: Stina Therese Sollid
4. Healthcare services, registry, and collaboration research (heart failure, coronary artery disease). Group leader: John Munkhaugen.

Our goal is to develop more personalized treatment and follow-up strategies to help both the general population and patients achieve and maintain optimal health and quality of life.